Carrington Announces Results Of Aliminase Clinical

Carrington Laboratories, Inc. announced the results of its Phase III pivotal trial with Aliminase for ulcerative colitis. Indications were that no significant differences were found to support a therapeutic drug effect. In light of these results, the company plans to discontinue the development and testing of Aliminase as a treatment for ulcerative colitis. “Although we Read more about Carrington Announces Results Of Aliminase Clinical[…]

medline industries

Carrington And Medline Sign Licensing Distribution Agreement

Carrington Laboratories, Inc., and Medline Industries, Inc., have formed a distribution licensing agreement under which Carrington has granted Medline the exclusive rights to sell and market Carrington’s wound and skin care products, the companies have announced. Carrington estimates the value of this agreement to be approximately $50 to $60 million over the five-year term of Read more about Carrington And Medline Sign Licensing Distribution Agreement[…]